Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal for Immunotherapy of Cancer|September 26, 2025
Addition of oncolytic virotherapy to clinical isolated limb perfusion for melanoma and sarcoma activates antitumor immunityAndrew J Hayes, Emma J Davies, Michelle Wilkinson, et al.Journal for Immunotherapy of Cancer|March 8, 2021
Differential and longitudinal immune gene patterns associated with reprogrammed microenvironment and viral mimicry in response to neoadjuvant radiotherapy in rectal cancerAnna Wilkins, Elisa Fontana, Gift Nyamundanda, et al.Gut|September 5, 2020
Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumoursKate Young, Rita T Lawlor, Chanthirika Ragulan, et al.Science Translational Medicine|January 26, 2018
Genetically modified lentiviruses that preserve microvascular function protect against late radiation damage in normal tissuesAadil A Khan, James T Paget, Martin McLaughlin, et al.Cancers|August 7, 2021
Quantitative Assessment and Prognostic Associations of the Immune Landscape in Ovarian Clear Cell CarcinomaSaira Khalique, Sarah Nash, David Mansfield, et al.Journal for Immunotherapy of Cancer|April 16, 2019
CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoidsReyes Gonzalez-Exposito, Maria Semiannikova, Beatrice Griffiths, et al.Nature Communications|May 24, 2025
Palbociclib and dsRNA sensor co-operate to enhance anti-cancer effects through ER stress and modulation of immune evasionVictoria Roulstone, Joan Kyula-Currie, James Wright, et al.Journal for Immunotherapy of Cancer|March 3, 2026
Effects of oncolytic immunotherapy with RP1 (vusolimogene oderparepvec) on immune cells mediate responsiveness to anti-PD-1 via STING-mediated interferon signalingVictoria Roulstone, Joan Kyula, Elizabeth Appleton, et al.The Journal of Clinical Investigation|November 7, 2023
Durable responses to ATR inhibition with ceralasertib in tumors with genomic defects and high inflammationMagnus T Dillon, Jeane Guevara, Kabir Mohammed, et al.Nature Communications|April 8, 2022
Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapyMarie-Eve Wedge, Victoria A Jennings, Mathieu J F Crupi, et al.Pageof 3